Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML)

Medical Oncology

Volumn 31, Issue 9, 2014, Pages 1-6

  Aref, Salah ^a   El Ghonemy, Mohamed Sabry ^a   Abouzeid, Tarek Elsayed ^a   El Sabbagh, Amr Mohamed ^a   El Baiomy, Mohamed Ali ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

AML; Mutation; Prognosis; TERT A1062T

Indexed keywords

EID: 84905319791     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0158-6     Document Type: Article

References (18)

1. Brown P. Adding WT1 to childhood AML alphabet soup. Blood. 2009;113(23):5696–7.
2. Gaidzik V, Schlenk R, Moschny S, Becker A, Bullinger L, Corbacioglu A, Krauter J, Brigitte S, Ganser A, Hartmut D, Konstanze D. Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML study group. Blood. 2009;113(19):4505–11.
3. Aalbers A, Calado R, Young N, Zwaan C, Wu C, Kajigaya S, Coenen E, Baruchel A, Geleijns K, de Haas V, Kaspers G, Kuijpers T, Reinhardt D, Trka J, Zimmermann M, Pieters R, van der Velden V, van den Heuvel-Eibrink M. Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia. Leukemia. 2013;27(8):1786–9.
4. Tallman M. Relevance of pathologic classifications and diagnosis of acute myeloid leukemia to clinical trials and clinical practice. Cancer Treat Res. 2004;121:45–67.
5. Yamaguchi H, Calado R, Ly H, Kajigaya S, Baerlocher G, Chanock S, Lansdorp P, Young N. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med. 2005;352:1413–24.
6. Blackburn E. Switching and signaling at the telomere. Cell. 2001;106:661–73.
7. Lansdorp P. Telomeres, stem cells, and hematology. Blood. 2008;111:1759–66.
8. Vulliamy T, Marronel A, Szydlol R, Walnel A, Mason P, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36:447–9.
9. Calado R, Regal J, Hills M, Yewdell W, Dalmazzo L, Zago M, Lansdorp P, Hogge D, Chanock S, Estey E, Falcao R, Young N. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci USA. 2009;106(4):1187–92.
10. Kim H, Kojima K, Swindle C, Cotta C, Huo Y, Reddy V, Klug C. FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia. Blood. 2008;111:1567–74.
11. Rudolph K, Chang S, Lee H, Blasco M, Gottlieb G, Greider C, DePinho R. Longevity, stress response, and cancer in aging telomerase deficient mice. Cell. 1999;96:701–12.
12. Yan S, Han B, Li H, Wu Y, Zhou D, Zhao Y. Telomerase gene screening and telomere overhang detection in Chinese patients with myelodysplastic syndrome. Leuk Res. 2013;37(10):1359–62.
13. Wagner K, Anna Both A, Damm F,Thol F, Göhring G, Heuser M, Ottmann O, et al. Clinical impact of TERT A1062T mutations in younger patients with acute myeloblastic leukemia. In: 54th ASH Annual Meeting and Exposition 2012, Atlanta, GA.
14. EL-Shakankiry N, EL-Sayed G, EL-Maghraby S, Moneer M. Bcl-2 protein expression in egyptian acute myeloid leukemia. J Egypt Nat Cancer Inst. 2009;21(1):71–6.
15. de Lange T. Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol. 2005;70:197–204.
16. Artandi S, Rtandi S, Chang S, Lee S, Alson S, Gottlieb G, Chin L, DePinho R. Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.
17. Gancarcíková M, Zemanová Z, Brezinová J, Berková A, Vcelíková S, Smigová J, Michalová K. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease. Prague Med Rep. 2010;111(2):91–105.
18. Ohyashiki K, Iwama H, Yahata N, Tauchi T, Kawakubo K, Shimamoto T, Ohyashiki J. Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation. Leuk Lymphoma. 2001;42(3):291–9.